Neuromedin U analogs comprising serum albumin binding amino acid residue

摘要

The present invention relates to neuromedin U receptor agonist peptides comprising at least one serum albumin binding amino acid residue, said serum albumin binding amino acid residue being distanced by at least one but less than 16 amino acids from the part of the peptide comprising the active site responsible for NMU receptor binding, as well as to pharmaceutical and veterinary compositions comprising the peptides.